Universidad Carlos III de Madrid

Universidad Carlos III de Madrid

Name of leader and affiliation
Juan José Vaquero, Departamento de Bioingeniería e Ingeniería Aeroespacial, Universidad Carlos III de Madrid, for scientific input.

Universidad Carlos III de Madrid, Departamento de Bioingeniería e Ingeniería Aeroespacial (UC3M-BIA) work is mainly focused on medical and molecular imaging technology research, and the use of such devices and methods in challenging, state-of-the-art biomedical experiments. This includes the development of new, application-driven technologies, advanced reconstruction and post-processing algorithms, and their practical application in the fields of CT, Nuclear Imaging, MRI and Optical Tomography. The group is markedly multidisciplinary covering the engineering aspects of the devices to the design of functionalized nanoparticles-based probes aimed to specific biomarkers. This work is done in close connection with real clinical and preclinical users, and collaborations with hospitals and biomedical research centers facilitate a fast validation of the results achieved, also enabling a fast transfer of results to the industry. Several devices developed by this group have reached a world-wide commercialization. With regard to the TB application, the group maintains a partnership with the Microbiology Department of the Hospital GU Gregorio Marañón (Madrid), whose solid experience in clinical and molecular biology tuberculosis facilitates translation of the results to clinical applications.



Sorry, no posts found for this author.

Consortium Partners

PreDiCT-TB brings together twenty-one leading European research partners in tuberculosis from both Industry and Academia

View More

The research leading to these results has received support from the Innovative Medicines Initiative Joint Undertaking under grant agreement n° 115337, resources of which are composed of financial contribution from the European Union's Seventh Framework Programme (FP7/2007-2013) and EFPIA companies’ in kind contribution.

The communication contained within this site reflects the author’s view and neither IMI nor the European Union and EFPIA are liable for any use that may be made of the information contained therein.